Levoketoconazole

Back to search

Molecule Structure

Scientific Name

Levoketoconazole

Description of the Drug

Levoketoconazole is one of two enantiomeric forms of racemic ketoconazole that strongly inhibits multiple steroidogenic enzymes and is used for the symptomatic treatment of endogenous Cushing’s syndrome.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05667

Brand Name(s)

Extina, Ketosidin, Ketozole, Nizoral, Nizoral A-D, Panfungol, Recorlev, Xolegel

Company Owner(s)

Strongbridge Dublin Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cytochrome P450 11B2 SINGLE PROTEIN INHIBITOR CHEMBL2722
Cytochrome P450 11B1 SINGLE PROTEIN INHIBITOR CHEMBL1908
Cytochrome P450 11A1 SINGLE PROTEIN INHIBITOR CHEMBL2033
Cytochrome P450 17A1 SINGLE PROTEIN INHIBITOR CHEMBL3522

Unichem Links

SureChEMBL SCHEMBL41473
PharmGKB PA450146
Human Metabolome Database HMDB0012242
DrugBank DB05667
PubChem: Thomson Pharma 16774807
PubChem 47576
NMRShiftDB 60058702
Nikkaji J301.870I
PDBe KLN
BindingDB 31768
EPA CompTox Dashboard DTXSID60161949
Brenda 6739 69472
Rhea 47518
rxnorm EXTINA NIZORAL XOLEGEL
PubChem: Drugs of the Future 12013789
ChEBI 47518
ZINC ZINC000000643153